SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.04.17 | Roche Outperform | Bernstein Research | |
| 28.04.17 | Roche Outperform | Bernstein Research | |
| 27.04.17 | Roche Outperform | Bernstein Research | |
| 27.04.17 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.04.17 | Roche buy | UBS AG | |
| 27.04.17 | Roche Hold | S&P Capital IQ | |
| 27.04.17 | Roche Hold | Kepler Cheuvreux | |
| 27.04.17 | Roche buy | Citigroup Corp. | |
| 26.04.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 26.04.17 | Novartis Underweight | Morgan Stanley | |
| 26.04.17 | Novartis Hold | Deutsche Bank AG | |
| 25.04.17 | Novartis Hold | S&P Capital IQ | |
| 21.04.17 | Novartis Neutral | UBS AG | |
| 20.04.17 | Roche buy | Jefferies & Company Inc. | |
| 19.04.17 | Novartis Underweight | Morgan Stanley | |
| 18.04.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.04.17 | Roche overweight | JP Morgan Chase & Co. | |
| 11.04.17 | Roche buy | Deutsche Bank AG | |
| 11.04.17 | Novartis Hold | Deutsche Bank AG | |
| 10.04.17 | Roche buy | Jefferies & Company Inc. | |
| 07.04.17 | Roche Reduce | HSBC | |
| 06.04.17 | Novartis Neutral | UBS AG | |
| 03.04.17 | Roche overweight | JP Morgan Chase & Co. | |
| 30.03.17 | Roche overweight | JP Morgan Chase & Co. | |
| 27.03.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.03.17 | Novartis buy | Kepler Cheuvreux | |
| 23.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 23.03.17 | Roche buy | Société Générale Group S.A. (SG) | |
| 23.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.03.17 | Roche buy | Deutsche Bank AG | |
| 23.03.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.03.17 | Novartis Hold | Deutsche Bank AG | |
| 15.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 14.03.17 | Novartis Neutral | UBS AG | |
| 10.03.17 | Novartis Hold | Deutsche Bank AG | |
| 09.03.17 | Novartis buy | Jefferies & Company Inc. | |
| 09.03.17 | Roche buy | Jefferies & Company Inc. | |
| 08.03.17 | Novartis Underweight | Barclays Capital |